Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass

被引:2
|
作者
Leyh, RG [1 ]
Kofidis, T [1 ]
Struber, M [1 ]
Fischer, S [1 ]
Knoblock, K [1 ]
Wachsmann, B [1 ]
Hagl, C [1 ]
Simon, AR [1 ]
Haverich, A [1 ]
机构
[1] Hannover Med Sch, Div Thorac & Cardiac Surg, D-3000 Hannover, Germany
来源
关键词
D O I
10.1016/j.jtcvs.2003.09.047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:896 / 896
页数:1
相关论文
共 50 条
  • [1] Methylene blue:: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
    Leyh, RG
    Kofidis, T
    Strüber, M
    Fischer, S
    Knobloch, K
    Wachsmann, B
    Hagl, C
    Simon, AR
    Haverich, A
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (06): : 1426 - 1431
  • [2] Use of Methylene Blue for Catecholamine-Refractory Vasoplegia from Protamine and Aprotinin
    Del Duca, Danny
    Sheth, Shashank S.
    Clarke, Ann E.
    Lachapelle, Kevin J.
    Ergina, Patrick L.
    ANNALS OF THORACIC SURGERY, 2009, 87 (02): : 640 - 642
  • [3] INTRAVENOUS ANGIOTENSIN II COMBINED WITH METHYLENE BLUE IN CATECHOLAMINE-REFRACTORY SHOCK
    Wiley, Tessa
    Beatrous, Kelsey
    Doherty, Joseph
    Artman, Katherine
    Dukes, Alan
    CRITICAL CARE MEDICINE, 2020, 48
  • [4] Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass
    Pagni, S
    Austin, EH
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (06): : 1297 - 1298
  • [5] Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation
    Carley, Michelle
    Schaff, Jacob
    Lai, Terrance
    Poppers, Jeremy
    A & A CASE REPORTS, 2015, 5 (08): : 127 - 130
  • [6] Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?
    Evora, PRB
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (03): : 632 - 633
  • [7] METHYLENE BLUE FOR REFRACTORY VASOPLEGIA IN INTENTIONAL ANTIHYPERTENSIVE OVERDOSE
    Phelps, Katelyn
    Nguyen, Larry
    Moreschi, Michelle
    Kerrigan, Chelsea
    CRITICAL CARE MEDICINE, 2020, 48
  • [8] Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
    Peyko, Vincent
    Finamore, Michael
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [9] Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass
    D. Pasero
    A. M. Berton
    G. Motta
    R. Raffaldi
    G. Fornaro
    A. Costamagna
    A. Toscano
    C. Filippini
    G. Mengozzi
    N. Prencipe
    M. Zavattaro
    F. Settanni
    E. Ghigo
    L. Brazzi
    A. S. Benso
    Journal of Endocrinological Investigation, 2021, 44 : 1533 - 1541
  • [10] Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? Reply
    Yiu, P
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (03): : 633 - 634